Postoperative Serum Interleukin 6 Concentrations Are Associated With Nutritional Status and Prognosis of Esophageal Cancer in the Minimally Invasive Esophagectomy Era
摘要
Findings have shown that preoperative serum interleukin 6 (IL-6) concentrations are associated with treatment response and prognosis of patients with esophageal cancer. However, it has been unclear whether IL-6 concentrations after minimally invasive esophagectomy (MIE) have an impact on nutritional status and prognosis.
MethodsThe cohort of this retrospective study comprised 336 patients who had undergone MIE with R0 for esophageal cancer from August 2020 to August 2022. The study investigated the relationship between postoperative serum IL-6 concentrations and outcomes.
ResultsThe study created low-IL-6 (<60 pg/mL) and high-IL-6 (≥60 pg/mL) groups according to the upper-quartile postoperative serum IL-6 concentration 1 day after MIE. The high-IL-6 group had a significantly worse overall survival (OS) (2-year OS rate, 69.8% in high-IL-6 vs 80.6% in low-IL-6 group; p = 0.004). A high IL-6 was independently and significantly associated with poor OS (odds ratio, 1.548; 95% confidence interval, 1.027–2.335; p = 0.037). Several indices of malnutrition, including the modified Glasgow prognostic score (mGPS), 1 month after surgery, were significantly lower in the high-IL-6 group than in the low-IL-6 group. Multivariate analysis identified high serum IL-6 concentration 1 day after surgery as an independent risk factor for malnutrition.
ConclusionThe ultra-early postoperative serum IL-6 concentration has a negative impact on the nutrition and prognosis of patients who have undergone MIE for esophageal cancer. Decreasing serum IL-6 concentrations after esophagectomy may improve nutritional status and prognosis. It may be important for perioperative management and treatment strategies to target IL-6 after esophageal cancer surgery.